Delivery Order SPE2DB22D2211-SPE2DB25FSERP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Fluticasone Propionate 50 mcg spray (16 gm) with a ceiling value of $1,730.88. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by September 11, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete task under a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Fluticasone Propionate 50 MCG Spray in 16GM units, with a ceiling value of $2,439.33. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is scheduled for ultimate completion on September 9, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,365.73 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray (16GM) on July 22, 2025, with completion scheduled for July 23, 2025. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical supply transaction executed under the company's existing contract vehicle with DLA. The award was placed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray (16GM) on September 10, 2025, with a ceiling value of $1,045.68 and firm fixed pricing. This non-set-aside, competitively awarded delivery order is scheduled for ultimate completion on September 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 micrograms spray (16-gram unit) valued at $1,396.90 under a firm fixed-price contract type. This delivery order, issued on August 19, 2025, represents a non-competitive set-aside and carries an ultimate completion date of August 20, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary...
- The Defense Logistics Agency awarded a delivery order valued at $1,563.24 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray (16GM) on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Fluticasone Propionate 50 MCG Spray in 16GM quantities, valued at $4,782.78 with a firm fixed price structure. This competitively awarded, non-set-aside delivery order is scheduled for completion by September 10, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $4,369.61 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Fluticasone Propionate 50 mcg spray in 16-gram units. The contract represents a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. Performance will be executed from the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Fluticasone Propionate 50 micrograms spray in 16-gram containers, with a ceiling value of $1,185.72. This firm fixed-price delivery order, with an ultimate completion date of August 15, 2025, represents a non-set-aside competitive award and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,442.72 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 mcg spray (16 grams) on August 13, 2025, with an ultimate completion date of August 14, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSERPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Fluticasone Propionate 50 MCG Spray in 16GM units, with a ceiling value of $3,025.30. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The work is scheduled for completion by September 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents one of numerous pharmaceutical supply transactions through which AmerisourceBergen fulfills critical medical procurement needs for the Department of Defense. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive prime vendor contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs globally. The arrangement provides DLA customers, including the Defense Health Agency and U.S. Coast Guard, with flexible access to essential pharmaceutical commodities across multiple therapeutic domains, supporting the department's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 9/10/25 |